Agile Therapeutics, Inc.
Transdermal Delivery
Last updated:
Abstract:
Dosing regimens for transdermal delivery of hormones comprising a 28 day treatment cycle with a fixed treatment interval and a fixed rest interval are disclosed.
Status:
Application
Type:
Utility
Filling date:
13 Oct 2020
Issue date:
28 Jan 2021